Asterias Biotherapeutics (AST) Set to Open Higher by 50% Following Positive Outcome from Safety Review Committee for AST-VAC2
Asterias Biotherapeutics (NYSE: AST) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
